Basics |
Rhythm Pharmaceuticals, Inc.
Rhythm Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders.
|
IPO Date: |
October 5, 2017 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$7.46B |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.79 | 2.92%
|
Avg Daily Range (30 D): |
$1.46 | 1.44%
|
Avg Daily Range (90 D): |
$1.53 | 1.71%
|
Institutional Daily Volume |
Avg Daily Volume: |
.4M |
Avg Daily Volume (30 D): |
.43M |
Avg Daily Volume (90 D): |
.53M |
Trade Size |
Avg Trade Size (Sh.): |
69 |
Avg Trade Size (Sh.) (30 D): |
36 |
Avg Trade Size (Sh.) (90 D): |
41 |
Institutional Trades |
Total Inst.Trades: |
2,678 |
Avg Inst. Trade: |
$2.5M |
Avg Inst. Trade (30 D): |
$8.07M |
Avg Inst. Trade (90 D): |
$5.29M |
Avg Inst. Trade Volume: |
.07M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$3.51M |
Avg Closing Trade (30 D): |
$13.53M |
Avg Closing Trade (90 D): |
$9.7M |
Avg Closing Volume: |
101.32K |
|
|
Financials |
|
TTM |
Q2 2025 |
Q1 2025 |
Basic EPS
|
$-3.01
|
$-.75
|
$-.81
|
Diluted EPS
|
$-3.01
|
$-.75
|
$-.81
|
Revenue
|
$ 156.29M
|
$ 48.5M
|
$ 32.7M
|
Gross Profit
|
$ 139.48M
|
$ 42.96M
|
$ 29.06M
|
Net Income / Loss
|
$ -183.06M
|
$ -46.63M
|
$ -49.5M
|
Operating Income / Loss
|
$ -177.44M
|
$ -45.3M
|
$ -47M
|
Cost of Revenue
|
$ 16.81M
|
$ 5.54M
|
$ 3.65M
|
Net Cash Flow
|
$ -26.11M
|
$ 29.83M
|
$ 16.96M
|
PE Ratio
|
|
|
|
|
|
|